Comparative efficacy and tolerability of adjuvant systemic treatments against resectable colon cancer: a network meta-analysis

BACKGROUND: Currently, 6-month oxaliplatin-based chemotherapy has been recommended as the preferred adjuvant treatment against high-risk stage 2 and stage 3 colon cancer patients. METHODS: Record retrieval was conducted in PubMed, Web of Science, Cochrane Central Register of Controlled Trials, Ameri...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ji, Shuai, Xiaoming, Gao, Jinbo, Wang, Guobin, Tao, Kaixiong, Cai, Kailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739130/
https://www.ncbi.nlm.nih.gov/pubmed/33403014
http://dx.doi.org/10.1177/1758835920974195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739130/
https://www.ncbi.nlm.nih.gov/pubmed/33403014
http://dx.doi.org/10.1177/1758835920974195

Ejemplares similares